What is the market doing?
What the tape says about AMRX
Amneal Pharmaceuticals, Inc. is +119% over the past year while the S&P 500 is +23%: 96 points ahead of the market.
+119%
1-year return · S&P 500 +23%
- vs 200-day average
- +31%
vs 200-day average · a clear uptrend
- RSI (14)
- 49
RSI (14) · neutral
- Below its 52-week high
- −4.6%
Below its 52-week high
Details›
- Last close2026-08-26
- $17.99
- 1 monthS&P 500 +3.7%
- +0.11%
- 1 yearS&P 500 +23%
- +119%
- 5 yearsS&P 500 +87%
- +260%
- vs 50-day average$16.84
- +6.8%
- 52-week high
- $18.86
- 52-week low
- $8.54
- Annualised volatility
- 35%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$451K
| Year | Return |
|---|---|
| 2026 (year to date) | +43% |
| 2025 | +59% |
| 2024 | +30% |
| 2023 | +205% |
| 2022 | −58% |
| 2021 | +4.8% |
| 2020 | −5.2% |
| 2019 | −64% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 4 of 8 | −0.85% |
| Feb | 8 | 6 of 8 | +1.6% |
| Mar | 8 | 3 of 8 | −3.0% |
| Apr | 8 | 3 of 8 | +0.40% |
| May | 8 | 5 of 8 | +2.4% |
| Jun | 9 | 3 of 9 | +2.6% |
| Jul | 9 | 5 of 9 | −1.1% |
| Aug | 9 | 5 of 9 | +2.8% |
| Sep | 8 | 3 of 8 | −0.51% |
| Oct | 8 | 6 of 8 | +1.2% |
| Nov | 8 | 4 of 8 | +3.8% |
| Dec | 8 | 5 of 8 | +6.2% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #22 of 28 by Smart Score